A.G. Behring Co.

Report summarizes glomerular disease study findings from G. Gluhovschi and co-researchers.
Biotech Week; 10/14/2009; 1583 words; ...the use of the Dimension (Dade Behring, Inc., Newark, DE, USA) clinical...treatment from 2.85 +/- 1.69 g/24h to 1.53 +/- 0.83 IT...decreased from 10.6 +/- 12.56 U/g creatinine to 6.44 7 U/g, a decrease that was statistically...

Research results from N. Rahemeyer and co-authors update knowledge of transfusion medicine.
Blood Weekly; 7/16/2009; 774 words; ...trigger for each therapy step was >= 60 g blood absorbed from the mediastinal wound...Haemocomplettan((R)) P/Riastap, CSL Behring, Marburg, Germany) before the algorithm-based therapy. A mean of 5.7 (0.7) g fibrinogen concentrate decreased blood loss...

Research on heart disease discussed by S.G. Foussas and co-researchers.(Report)
Heart Disease Weekly; 5/17/2009; 1438 words; ...by the Platelet Function Analyzer-loo (PFA-100) (Dade Behring Inc., Deerfield, ILL., USA) on the long-term prognosis...CI = 1.7-4.6; p-value < 0.001)," wrote S.G. Foussas and colleagues (see also Heart Disease). The researchers...

Insight on Global Investment Opportunities, Analysis and Forecasts to 2012.
M2 Presswire; 1/14/2009; 910 words; ...Roche Ltd. - Beckman Coulter, Inc. - Dade Behring Holdings, Inc. - Abbott Laboratories...454 Life Sciences Corporration - A&G Pharmaceutical, Inc. - Abbott Diagnostics...Bio-Medicals Ltd. - J.Mitra & Co. Ltd. - Jindal Medical & Scientific...

Research and Markets: Insight on Global Investment Opportunities, Analysis and Forecasts to 2012.
Business Wire; 1/14/2009; 856 words; ...Roche Ltd. * Beckman Coulter, Inc. * Dade Behring Holdings, Inc. * Abbott Laboratories...454 Life Sciences Corporation * A&G Pharmaceutical, Inc. * Abbott Diagnostics...Bio-Medicals Ltd. * J.Mitra & Co. Ltd. * Jindal Medical & Scientific...